Palatsi R, Reinilä M, Kivinén S
Acta Derm Venereol. 1986;66(3):225-30.
Pituitary function (TRH-LHRH stimulation test) was investigated in male acne patients and serum levels of dehydroepiandrosterone sulphate (DHEA-S), sex hormone binding globulin (SHBG) and other biochemical parameters were investigated in male acne patients and in female acne patients before and after treatment with an oral contraceptive. The TRH-LHRH stimulation test was performed with 15 male patients suffering from severe cystic acne and 7 healthy volunteers. Basal and stimulated prolactin, LH and FSH levels were statistically similar in the patients and control groups. However, the stimulated LH levels of the patients were 60% higher than those in controls. SHBG levels were significantly) higher in the patient group compared to those in the control group. Thirty-three female acne patients were randomly divided into two groups and treated for six months with an oral contraceptive containing 0.030 mg ethinylestradiol (EE) plus 0.150 mg levonorgestrel or 0.150 mg levonorgestrel. After six months' treatment a 30% decrease in DHEA-S levels were observed in the desogestrel/EE group and a 15% decrease in the levonorgestrel/EE group; the difference was not statistically significant. At the same time serum total cortisol increased by 75-100% and free testosterone fell by 30-40% in both groups, whereas SHBG elevated 250% in the desogestrel/EE group and 30% in the levonorgestrel/EE group. Acne improved significantly in both groups, desogestrel/EE showing greater improvement. A decrease in SHBG and increase in DHEA-S levels appear to be the most common hormonal changes in acne. Oral contraceptive treatment induces an increase in SHBG and decrease in DHEA-S and also improves acne.
对男性痤疮患者的垂体功能(促甲状腺激素释放激素 - 促性腺激素释放激素刺激试验)进行了研究,并对男性痤疮患者以及女性痤疮患者在口服避孕药治疗前后的硫酸脱氢表雄酮(DHEA - S)、性激素结合球蛋白(SHBG)水平及其他生化参数进行了研究。对15名患有重度囊肿性痤疮的男性患者和7名健康志愿者进行了促甲状腺激素释放激素 - 促性腺激素释放激素刺激试验。患者组和对照组的基础及刺激后的催乳素、促黄体生成素(LH)和促卵泡生成素(FSH)水平在统计学上相似。然而,患者组刺激后的LH水平比对照组高60%。与对照组相比,患者组的SHBG水平显著更高。33名女性痤疮患者被随机分为两组,分别用含0.030毫克炔雌醇(EE)加0.150毫克左炔诺孕酮或0.150毫克左炔诺孕酮的口服避孕药治疗6个月。治疗6个月后,去氧孕烯/EE组的DHEA - S水平下降了30%,左炔诺孕酮/EE组下降了15%;差异无统计学意义。同时,两组的血清总皮质醇均升高了75 - 100%,游离睾酮均下降了30 - 40%,而去氧孕烯/EE组的SHBG升高了250%,左炔诺孕酮/EE组升高了30%。两组的痤疮均有显著改善,去氧孕烯/EE组改善更明显。SHBG降低和DHEA - S水平升高似乎是痤疮最常见的激素变化。口服避孕药治疗可使SHBG升高、DHEA - S降低,同时改善痤疮。